EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modified unlocked nucleic acid (MUNA) mitigates off-target effects of small interfering RNAs

Shohei Mori iD, Dhrubajyoti Datta, Lydia Perkins, Michelle Jung, Lauren Blair Woods, Alex Eaton, June Qin, Tim Racie, MaryBeth Kim, Dale C Guenther, Adam Castoreno, Mark K Schlegel iD und 4 weitere

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Shohei Mori und 15 weiteren Autor:innen. Beteiligte Einrichtung: Alnylam Pharmaceuticals, 675 West Kendall, Cambridge, MA 02142, United States. Hauptthemen laut MEDLINE: RNA, Small Interfering, RNA Interference, Nucleic Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alnylam Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Unlocked nucleic acid (UNA) is a nucleic acid analog that has an acyclic ribose ring lacking the bond between C2′ and C3′ atoms. The base-pairing properties of UNA have been studied, and it has been used as a scaffold for conjugation, but the chemical space around UNA and its potential applications in the context of short interfering RNAs (siRNAs), which mediate RNA interference, have not been thoroughly explored. In this study, we report syntheses of methylated and methoxylated UNAs and their incorporation into siRNAs. siRNAs with 5′-(R)-methyl-UNA and with 5′-(S)-methyl-UNA in the seed region had comparable potencies but reduced off-target effects compared to siRNA modified with UNA. In mice, siRNAs with modified UNAs were of comparable potency to an siRNA of the same sequence and chemistry lacking UNA. Modeling studies indicated that the flexibilities of UNA and the modified UNAs facilitate kinking of the antisense strand when incorporated at position 7. These findings highlight the potential of modified UNA for advancing therapeutics that act through the RNA interference pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingRNA InterferenceNucleic AcidsAnimalsMiceHumansNucleic Acid ConformationBase Pairing

Substanzen

RNA, Small InterferingNucleic Acids

Autor:innen und Institutionen

  • Alnylam Pharmaceuticals, 675 West Kendall, Cambridge, MA 02142, United States.
  • Department of Biochemistry and Center for Structural Biology, Vanderbilt University, School of Medicine, Nashville, TN 37232-0146, United States.

ORCID-Profile: Shohei Mori, Mark K Schlegel, Martin Egli, Muthiah Manoharan

Förderung

  • Alnylam Pharmaceuticals

Zitieren

APA

Mori, S., Datta, D., Perkins, L., Jung, M., Woods, L. B., Eaton, A., Qin, J., Racie, T., Kim, M., Guenther, D. C., Castoreno, A., Schlegel, M. K., Charisse, K., Egli, M., Matsuda, S., & Manoharan, M. (2025). Modified unlocked nucleic acid (MUNA) mitigates off-target effects of small interfering RNAs. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf937

Vancouver

Mori S, Datta D, Perkins L, Jung M, Woods LB, Eaton A, et al. Modified unlocked nucleic acid (MUNA) mitigates off-target effects of small interfering RNAs. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf937

BibTeX
@article{Mori2025,
  author = {Mori, Shohei and Datta, Dhrubajyoti and Perkins, Lydia and Jung, Michelle and Woods, Lauren Blair and Eaton, Alex and Qin, June and Racie, Tim and Kim, MaryBeth and Guenther, Dale C and Castoreno, Adam and Schlegel, Mark K and Charisse, Klaus and Egli, Martin and Matsuda, Shigeo and Manoharan, Muthiah},
  title = {Modified unlocked nucleic acid (MUNA) mitigates off-target effects of small interfering RNAs},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf937}
}
Kostenlos starten →